| Eight-color multiplex immunohistochemistry for simultaneous detection of multiple immune checkpoint molecules within the tumor microenvironment MAJ Gorris, A Halilovic, K Rabold, A van Duffelen, IN Wickramasinghe, ... The Journal of Immunology 200 (1), 347-354, 2018 | 234 | 2018 |
| The clinical application of cancer immunotherapy based on naturally circulating dendritic cells KF Bol, G Schreibelt, K Rabold, SK Wculek, JK Schwarze, A Dzionek, ... Journal for immunotherapy of cancer 7 (1), 1-13, 2019 | 168 | 2019 |
| Cellular metabolism of tumor‐associated macrophages–functional impact and consequences K Rabold, MG Netea, GJ Adema, RT Netea‐Maier FEBS letters 591 (19), 3022-3041, 2017 | 69 | 2017 |
| In vitro induction of trained immunity in adherent human monocytes J Domínguez-Andrés, RJW Arts, S Bekkering, H Bahrar, BA Blok, ... STAR protocols 2 (1), 100365, 2021 | 59 | 2021 |
| Enhanced lipid biosynthesis in human tumor-induced macrophages contributes to their protumoral characteristics K Rabold, A Aschenbrenner, C Thiele, CK Boahen, A Schiltmans, ... Journal for Immunotherapy of Cancer 8 (2), 2020 | 46 | 2020 |
| Metabolic programming of tumor associated macrophages in the context of cancer treatment T Crezee, K Rabold, L de Jong, M Jaeger, RT Netea-Maier Annals of Translational Medicine 8 (16), 2020 | 24 | 2020 |
| Effect of PTEN inactivating germline mutations on innate immune cell function and thyroid cancer-induced macrophages in patients with PTEN hamartoma tumor syndrome YJE Sloot, K Rabold, MG Netea, JWA Smit, N Hoogerbrugge, ... Oncogene 38 (19), 3743-3755, 2019 | 23 | 2019 |
| NRAS-mutated melanocytic BAP1-associated intradermal tumor (MBAIT): a case report WAM Blokx, K Rabold, HJ Bovenschen, MJL Ligtenberg, ... Virchows Archiv 466, 117-121, 2015 | 16 | 2015 |
| Interplay between thyroid cancer cells and macrophages: effects on IL-32 mediated cell death and thyroid cancer cell migration YJE Sloot, K Rabold, T Ulas, DM De Graaf, B Heinhuis, K Händler, ... Cellular Oncology 42, 691-703, 2019 | 9 | 2019 |
| Reprogramming of myeloid cells and their progenitors in patients with non-medullary thyroid carcinoma K Rabold, M Zoodsma, I Grondman, Y Kuijpers, M Bremmers, M Jaeger, ... Nature communications 13 (1), 1-14, 2022 | 7 | 2022 |
| T‐Cell Lymphopenia in Patients with Advanced Thyroid Carcinoma Is Associated with Poor Prognosis K Rabold, PR Gielen, ED Kers‐Rebel, MG Netea, JWA Smit, GJ Adema, ... The Oncologist 24 (3), e106-e110, 2019 | 6 | 2019 |
| Copy number variations as potential diagnostic and prognostic markers for CNS melanocytic neoplasms in neurocutaneous melanosis ACH van Engen-van Grunsven, K Rabold, HVN Küsters-Vandevelde, ... Acta neuropathologica 133, 333-335, 2017 | 6 | 2017 |
| Influence of Lenvatinib on the Functional Reprogramming of Peripheral Myeloid Cells in the Context of Non-Medullary Thyroid Carcinoma C Peng, K Rabold, MG Netea, M Jaeger, RT Netea-Maier Pharmaceutics 15 (2), 412, 2023 | 2 | 2023 |
| IGF2 is a potential factor in RAI‑refractory differentiated thyroid cancer T Crezee, MH Tesselaar, M Jaeger, K Rabold, WE Corver, H Morreau, ... Oncology Letters 22 (2), 1-9, 2021 | 1 | 2021 |
| induction of trained immunity in adherent human monocytes. J Domínguez-Andrés, RJW Arts, S Bekkering, H Bahrar, BA Blok, ... Cell Press, 2021 | | 2021 |
| BRAFV600E Inhibitor Radiosensitizes Thyroid Cancer EL Göttgens, K Rabold, PN Span Clinical Cancer Research 25 (21), 6556-6556, 2019 | | 2019 |
| The clinical application of cancer immunotherapy based on naturally circulating dendritic cells G Coukos, J Vries, I Melero, D Sancho, B Neyns, KF Bol, G Schreibelt, ... BMJ, 2019 | | 2019 |
| Genomic analysis of leptomeningeal and skin melanocytic tumors in neurocutaneous melanosis; potential clues for diagnosis and prognosis ACH van Engen-van Grunsven, K Rabold, HVN Küsters-Vandevelde, ... Genetic alterations in rare subtypes of melanocytic tumors, 125, 2017 | | 2017 |
| The interplay between immune cell function and thyroid cancer development in patients with Cowden syndrome YJE Sloot, K Rabold, MG Netea, JW Smit, N Hoogerbrugge, ... | | |
